Phibro Animal Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Phibro Animal Health generated cash of $87,594,000, which is more than the previous year. Cash used in financing activities reached the amount of -$6,768,000 last year. Net change in cash is therefore $29,332,000.
Cash Flow
| 2015 | 68.70M | -34.46M | -15.35M |
|---|---|---|---|
| 2016 | 37.21M | -82.79M | 50.38M |
| 2017 | 98.4M | -21.9M | -53.73M |
| 2018 | 70.00M | -84.61M | -11.77M |
| 2019 | 47.16M | -14.13M | -4.10M |
| 2020 | 59.34M | -120.39M | 40.93M |
| 2021 | 48.30M | -18.58M | -16.99M |
| 2022 | 31.64M | -22.58M | 16.34M |
| 2023 | 13.31M | -74.01M | 26.98M |
| 2024 | 87.59M | -48.19M | -6.76M |
PAHC Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 41.28M | 74.24M | 50.21M | 36.34M | 57.57M | 29.16M | 56.08M | 33.60M | 29.21M | 11.82M |
Operating activities | ||||||||||
Net income | 2.41M | 32.60M | 49.17M | 54.38M | 33.55M | 54.71M | 64.88M | 64.61M | 82.72M | 60.28M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 36.17M | 34.01M | 32.70M | 31.88M | 32.34M | 27.56M | 26.94M | 26.00M | 23.45M | 21.60M |
Stock-based compensation expense | 475K | 0 | 0 | 1.12M | 2.25M | 2.25M | 334K | 0 | 0 | 0 |
| Deferred income tax benefit | 475K | 0 | 0 | 1.12M | 2.25M | 2.25M | 334K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -8.67M | 5.33M | -23.62M | -18.20M | 28.71M | -23.67M | -11.9M | -2.76M | -13.08M | -1.87M |
Inventories | 2.64M | -11.22M | -46.99M | -12.49M | -12.93M | -20.98M | -24.29M | 5.43M | -16.43M | -19.35M |
Accounts payable | 12M | -22.83M | 26.35M | 3.17M | -7.67M | 12.09M | 2.44M | -3.11M | -3.24M | 4.79M |
Cash generated by operating activities | 87.59M | 13.31M | 31.64M | 48.30M | 59.34M | 47.16M | 70.00M | 98.4M | 37.21M | 68.70M |
Investing activities | ||||||||||
Purchases Of Investments | -65.52M | -40M | -64.1M | -74M | -80M | -34M | -82M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -41.23M | -51.79M | -37.04M | -29.32M | -34.04M | -29.89M | -18.54M | -20.9M | -36.35M | -20.05M |
Acquisitions Net | -3.28M | 51.79M | -13.51M | 29.32M | -54.54M | -9.83M | -15M | 0 | -46.57M | -10.37M |
Cash generated by investing activities | -48.19M | -74.01M | -22.58M | -18.58M | -120.39M | -14.13M | -84.61M | -21.9M | -82.79M | -34.46M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 1.13M | 5.69M | 5.54M | 4.01M | 1.33M |
Payments for dividends | -19.44M | -19.44M | -19.44M | -19.43M | -19.41M | -18.59M | -16.07M | -15.82M | -15.70M | -15.59M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 12.70M | 42.68M | 40.62M | -612.12M | -182.64M | 13.35M | -226.40M | -39.52M | -193.42M | -1.09M |
Cash used in financing activities | -6.76M | 26.98M | 16.34M | -16.99M | 40.93M | -4.10M | -11.77M | -53.73M | 50.38M | -15.35M |
Net Change In Cash | 29.33M | -32.96M | 24.03M | 13.86M | -21.23M | 28.40M | -26.91M | 22.47M | 4.38M | 17.39M |
Cash at end of period | 70.61M | 41.28M | 74.24M | 50.21M | 36.34M | 57.57M | 29.16M | 56.08M | 33.60M | 29.21M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |